Cite
Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.
MLA
Felizardo, Raphael J. F., et al. “Gut Microbial Metabolite Butyrate Protects against Proteinuric Kidney Disease through Epigenetic- and GPR109a-Mediated Mechanisms.” FASEB Journal, vol. 33, no. 11, Nov. 2019, pp. 11894–908. EBSCOhost, https://doi.org/10.1096/fj.201901080R.
APA
Felizardo, R. J. F., de Almeida, D. C., Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. S., Ribeiro, W. R., Cenedeze, M. A., Hiyane, M. I., Amano, M. T., Braga, T. T., Ferreira, C. M., Parmigiani, R. B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Mariño, E., Robert, R., Mackay, C. R., & Camara, N. O. S. (2019). Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. FASEB Journal, 33(11), 11894–11908. https://doi.org/10.1096/fj.201901080R
Chicago
Felizardo, Raphael J. F., Danilo C. de Almeida, Rafael L. Pereira, Ingrid K. M. Watanabe, Nayara T. S. Doimo, Willian R. Ribeiro, Marcos A. Cenedeze, et al. 2019. “Gut Microbial Metabolite Butyrate Protects against Proteinuric Kidney Disease through Epigenetic- and GPR109a-Mediated Mechanisms.” FASEB Journal 33 (11): 11894–908. doi:10.1096/fj.201901080R.